Literature DB >> 7403809

Scales for rating psychotic and psychotic-like experiences as continua.

L J Chapman, J P Chapman.   

Abstract

Although psychotic symptoms are usually viewed as dichotomous events, both patients and nonpatients often report isolated psychotic experiences as well as psychotic-like experiences, the latter being attenuated versions of psychotic experiences. College students, previously identified as probably at high risk for psychosis, were interviewed using a modified Schedule for Affecting Disorders and Schizophrenia--Lifetime Version (SADS L). Eighty types of deviant experiences reported in the interviews fell into six categories: transmission of one's own thoughts, passivity experiences, thought withdrawal, voice and other auditory experiences, aberrant beliefs, and visual experiences. The 80 types of experience were rated on deviancy by six expert judges (coefficient alpha of raters = .94). The median ratings of the six judges were used to construct a manual. Two pairs of raters used the manual to rate excerpts of interview and obtained reliabilities of .78 and .81. This manual should be useful in evaluation of psychotic-like experiences, especially in studies of individuals believed to be at high risk for future development of clinical psychosis.

Entities:  

Mesh:

Year:  1980        PMID: 7403809

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  32 in total

1.  The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal; Paul J Silvia
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

2.  Common neural circuitry supporting volitional saccades and its disruption in schizophrenia patients and relatives.

Authors:  Jazmin Camchong; Kara A Dyckman; Benjamin P Austin; Brett A Clementz; Jennifer E McDowell
Journal:  Biol Psychiatry       Date:  2008-08-09       Impact factor: 13.382

3.  The near Babylonian speech confusion in early detection of psychosis.

Authors:  Frauke Schultze-Lutter; Benno G Schimmelmann; Stephan Ruhrmann
Journal:  Schizophr Bull       Date:  2011-05-09       Impact factor: 9.306

4.  The Iowa multiplex family study of schizophrenia: linkage analyses on chromosome 5.

Authors:  R R Crowe; D W Black; N C Andreasen; M Huether
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

5.  Jumping to Conclusions About the Beads Task? A Meta-analysis of Delusional Ideation and Data-Gathering.

Authors:  Robert Malcolm Ross; Ryan McKay; Max Coltheart; Robyn Langdon
Journal:  Schizophr Bull       Date:  2015-01-22       Impact factor: 9.306

6.  The relationship between temperament and character and subclinical psychotic-like experiences in healthy adults.

Authors:  G C Nitzburg; A K Malhotra; P DeRosse
Journal:  Eur Psychiatry       Date:  2014-01-16       Impact factor: 5.361

7.  Testing the continuum of delusional beliefs: an experimental study using virtual reality.

Authors:  Daniel Freeman; Katherine Pugh; Natasha Vorontsova; Angus Antley; Mel Slater
Journal:  J Abnorm Psychol       Date:  2010-02

8.  Tailoring the definition of the clinical schizophrenia phenotype in linkage studies.

Authors:  Verena Krause; Olga Krastoshevsky; Michael J Coleman; J Alexander Bodkin; Jan Lerbinger; Lenore Boling; Fred Johnson; Anne Gibbs; Jonathan O Cole; Zhuying Huang; Nancy R Mendell; Deborah L Levy
Journal:  Schizophr Res       Date:  2009-11-26       Impact factor: 4.939

Review 9.  Social predictors of psychotic experiences: specificity and psychological mechanisms.

Authors:  Richard P Bentall; Charles Fernyhough
Journal:  Schizophr Bull       Date:  2008-08-14       Impact factor: 9.306

10.  What makes one person paranoid and another person anxious? The differential prediction of social anxiety and persecutory ideation in an experimental situation.

Authors:  D Freeman; M Gittins; K Pugh; A Antley; M Slater; G Dunn
Journal:  Psychol Med       Date:  2008-06-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.